Gene and Cell Therapy: Biology and Applications (eBook)
XV, 305 Seiten
Springer Singapore (Verlag)
978-981-13-0481-1 (ISBN)
Recent advances in stem cell biology, nanotechnology and gene therapy have opened new avenues for therapeutics. The availability of molecular therapeutics that rely on the delivery of DNA, RNA or proteins, harnessing enhanced delivery with nanoparticles, and the regenerative potential of stem cells (adult, embryonic or induced pluripotent stem cells) has had a tremendous impact on translational medicine. The chapters in this book cover a range of strategies for molecular and cellular therapies for human disease, their advantages, and central challenges to their widespread application. Potential solutions to these issues are also discussed in detail. Further, the book addresses numerous advances in the field of molecular therapeutics that will be of interest to the general scientific community. Lastly, the book provides specific examples of disease conditions for which these strategies have been transferred to the clinic. As such, it will be extremely useful for all students, researchers and clinicians working in the field of translational medicine and molecular therapeutics.
Dr. Giridhara R. Jayandharan is currently working as an Associate Professor at Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India. Dr. Jayandharan completed his PhD from Christian Medical College, Vellore, India in the year 2006 and subsequently worked as post-doctoral fellow at University of Florida, Gainesville, USA between the year 2007-2009 where he worked extensively on Gene Therapy. Before joining the coveted Indian Institute of Technology, he worked as a faculty member in the Department of Hematology and also at Center for Stem Cell Research, Christian Medical College, Vellore, India. His main area of research includes Gene transfer and therapy, Human molecular genetics and Virology.
Dr. Jayandharan is a prolific publisher as he has over 60 papers in peer reviewed high quality journals. He is recipient of several awards and honors. Most notable awards received by him are; Wellcome Trust DBT senior fellowship, Swarnajayanthi fellowship from Department of Science and Technology, Government of India, Young scientist award, YIM Boston, USA; Senior Innovative Young Biotechnologist award, Department of Biotechnology, Government of India; Bayer Hemophilia Early Career Investigator Award, Bayer Inc, USA etc.
Dr. Jayandharan is a member of several notable academies/societies such as International Society for Thrombosis and Hemostasis, European Society for Gene and Cell Therapy, American Society for Gene and Cellular Therapy.Recent advances in stem cell biology, nanotechnology and gene therapy have opened new avenues for therapeutics. The availability of molecular therapeutics that rely on the delivery of DNA, RNA or proteins, harnessing enhanced delivery with nanoparticles, and the regenerative potential of stem cells (adult, embryonic or induced pluripotent stem cells) has had a tremendous impact on translational medicine. The chapters in this book cover a range of strategies for molecular and cellular therapies for human disease, their advantages, and central challenges to their widespread application. Potential solutions to these issues are also discussed in detail. Further, the book addresses numerous advances in the field of molecular therapeutics that will be of interest to the general scientific community. Lastly, the book provides specific examples of disease conditions for which these strategies have been transferred to the clinic. As such, it will be extremely useful for all students, researchers and clinicians working in the field of translational medicine and molecular therapeutics.
Dr. Giridhara R. Jayandharan is currently working as an Associate Professor at Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India. Dr. Jayandharan completed his PhD from Christian Medical College, Vellore, India in the year 2006 and subsequently worked as post-doctoral fellow at University of Florida, Gainesville, USA between the year 2007-2009 where he worked extensively on Gene Therapy. Before joining the coveted Indian Institute of Technology, he worked as a faculty member in the Department of Hematology and also at Center for Stem Cell Research, Christian Medical College, Vellore, India. His main area of research includes Gene transfer and therapy, Human molecular genetics and Virology. Dr. Jayandharan is a prolific publisher as he has over 60 papers in peer reviewed high quality journals. He is recipient of several awards and honors. Most notable awards received by him are; Wellcome Trust DBT senior fellowship, Swarnajayanthi fellowship from Department of Science and Technology, Government of India, Young scientist award, YIM Boston, USA; Senior Innovative Young Biotechnologist award, Department of Biotechnology, Government of India; Bayer Hemophilia Early Career Investigator Award, Bayer Inc, USA etc.Dr. Jayandharan is a member of several notable academies/societies such as International Society for Thrombosis and Hemostasis, European Society for Gene and Cell Therapy, American Society for Gene and Cellular Therapy.
Chapter 1. Retroviral vectors in gene therapy.- Chapter 2. Adeno-associated virus vectors in gene therapy.- Chapter 3. Nanoparticle-mediated gene delivery.- Chapter 4. Viral/non-viral based hybrid vectors for gene therapy.- Chapter 5. Pharmaco-gene therapy: an alternate perspective.- Chapter 6. Aptamers - Novel molecules in therapeutics.- Chapter 7. Induced pluripotent stem cells.- Chapter 8. Hope or Hype: Stem cells as therapeutics in retinal degenerative diseases.- Chapter 9. Hematopoeitic stem cells: past, present and future.
| Erscheint lt. Verlag | 12.9.2018 |
|---|---|
| Zusatzinfo | XV, 305 p. 47 illus. |
| Verlagsort | Singapore |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Biomedizin |
| Medizin / Pharmazie ► Physiotherapie / Ergotherapie ► Orthopädie | |
| Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik | |
| Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie | |
| Naturwissenschaften ► Biologie ► Zellbiologie | |
| Technik ► Medizintechnik | |
| Schlagworte | Aptamers • Cell Therapy • gene therapy • Nano particles • Stem Cells |
| ISBN-10 | 981-13-0481-5 / 9811304815 |
| ISBN-13 | 978-981-13-0481-1 / 9789811304811 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 7,2 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
